Check out this Bloomberg Law article where DrugPatentWatch shows how the number of patent challenges is increasing, while the number of challengers of each patent is also increasing. Why might this…
The post DrugPatentWatch and Bloomberg: Are there too…
DrugPatentWatch and Bloomberg: Are there too many generic patent challenges? Read Post »
Check out the latest issue of Lab Manager where I discuss my interest in informatics, the complexities of informatics for today’s scientists, and some of the tools available. https://www.labmanager.com/ask-the-expert/trends-in-informatics-22895
The pos…
In response to customer requests, we’ve built some new tools for formulary management. You can preview these tools at: Recent Generic Drug Launches Upcoming 180-Day Patent Challenge Exclusivity Expirations Anticipate…
The post Customer Success: Formula…
Let DrugPatentWatch build custom dashboards and reports to take the load off of your team. We can ensure the production of accurate, objective, and timely intelligence to help you quickly…
The post Automated Reports and Custom Dashboards appeared first…
This article was originally published by Hermann Mucke & Peter Mucke in Future Drug Discovery under a Attribution-NonCommercial-NoDerivatives 4.0 Unported License. https://doi.org/10.4155/fdd-2020-0001. Drug developers require access to scientific info…
In a recent court ruling, the U.S. Court of Appeals for the Federal Circuit (CAFC) denied a petition to rehear arguments regarding the invalidity of patent claims containing the phrase…
The post 244 Drug Patents With Claims Containing “consisting essen…
244 Drug Patents With Claims Containing “consisting essentially of” may be Unenforceable Read Post »
One of our clients, the Belarus Republican Scientific and Technical Library recently posted an article on how they support innovation. They open with the statement that “The novelty, effectiveness and…
The post Customer Success: DrugPatentWatch for You…
Customer Success: DrugPatentWatch for Your Library Read Post »
I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities at the 13th Annual Pharma Resource Planning & Portfolio Management in Philadelphia, PA on February 6th, 2020. You can…
The post Upcoming Talk: Finding and Evaluating BioPharmace…
Upcoming Talk: Finding and Evaluating BioPharmaceutical Market Entry Opportunities Read Post »
DrugPatentWatch was used in a recent research study on branded drug sales following generic entry. In this paper, authors Jeffrey Fujimoto, Daniel M Tien, Sophie Snyder, Jeppe A Hertz, and…
The post The effect of patent expiration on sales of branded c…
DrugPatentWatch serves companies across the drug development-delivery sector. A common request among drug manufacturers, payers, and suppliers alike is anticipation of which branded drugs will face generic competition, and when…
The post Customer Succe…
Customer Success: Will a generic version of a drug launch? And when? Read Post »